Namibia vs United States of America: Share of one-year-olds vaccinated against rotavirus
Namibia
75.0%
in 2024
United States of America
77.0%
in 2024
Namibia rank
69th
United States of America rank
67th
Share of one-year-olds vaccinated against rotavirus over time
- Namibia
- United States of America
How they compare
United States of America currently reports 77.0% against 75.0% in Namibia, a difference of 2.0%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Namibia ahead.
Namibia ranks 69th and United States of America ranks 67th of 108 countries.
Across the 2 decades both report, Namibia averaged higher in 1 and United States of America in 1.
Head to head by decade
| Decade | Namibia | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.2% | 73.2% | 15.0% | Namibia |
| 2020s | 67.2% | 76.4% | 9.2% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against rotavirus, Namibia or United States of America?
- United States of America, at 77.0% against 75.0% in Namibia as of 2024.
- What is the difference in share of one-year-olds vaccinated against rotavirus between Namibia and United States of America?
- 2.0%, with United States of America ahead.
- How many years of comparable data are there for Namibia and United States of America?
- 10 years are reported by both, from 2015 to 2024.
- How do Namibia and United States of America rank globally for share of one-year-olds vaccinated against rotavirus?
- Namibia ranks 69th and United States of America ranks 67th of 108 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against rotavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the final recommended dose (2nd or 3rd) of the rotavirus vaccine in a given year.